{
  "symbol": "MO",
  "year": 2022,
  "Period": "Q2",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.2062,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.168
  },
  "top_positive": [
    {
      "sent": "43 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 4,278 $ 1,428 $ 2,850 $ 2,850 $ 1.57 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 9 2 7 7 \u2014 Tobacco and health and certain other litigation items 58 14 44 44 0.02 JUUL changes in fair value 1,255 \u2014 1,255 1,255 0.70 ABI-related special items 53 11 42 42 0.02 Cronos-related special items 175 8 167 167 0.09 Income tax items \u2014 (9) 9 9 \u2014 2022 Adjusted for Special Items $ 5,768 $ 1,439 $ 4,329 $ 4,329 $ 2.38 2021 Reported $ 4,846 $ 1,275 $ 3,571 $ 3,573 $ 1.93 NPM Adjustment Items (32) (8) (24) (24) (0.01) Asset impairment, exit, implementation, acquisition and disposition-related costs 56 13 43 43 0.02 Tobacco and health and certain other litigation items 43 10 33 33 0.02 JUUL changes in fair value 100 \u2014 100 100 0.05 ABI-related special items (89) (18) (71) (71) (0.04) Cronos-related special items 111 (5) 116 116 0.06 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 (3) 3 3 \u2014 2021 Adjusted for Special Items $ 5,684 $ 1,417 $ 4,267 $ 4,269 $ 2.30 44 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 1,605 $ 714 $ 891 $ 891 $ 0.49 Asset impairment, exit, implementation, acquisition and disposition-related costs 2 \u2014 2 2 \u2014 Tobacco and health and certain other litigation items 46 11 35 35 0.02 JUUL changes in fair value 1,155 \u2014 1,155 1,155 0.64 ABI-related special items 112 23 89 89 0.05 Cronos-related special items 114 8 106 106 0.06 Income tax items \u2014 (4) 4 4 \u2014 2022 Adjusted for Special Items $ 3,034 $ 752 $ 2,282 $ 2,282 $ 1.26 2021 Reported $ 2,909 759 $ 2,150 $ 2,149 $ 1.16 Asset impairment, exit, implementation, acquisition and disposition-related costs 8 2 6 6 \u2014 Tobacco and health and certain other litigation items 8 1 7 7 \u2014 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 39 10 29 29 0.02 Cronos-related special items 181 (5) 186 186 0.10 Income tax items \u2014 (9) 9 9 \u2014 2021 Adjusted for Special Items $ 3,045 $ 758 $ 2,287 $ 2,286 $ 1.23 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11 and NPM Adjustment Items in Note 8, respectively.",
      "score": 0.9958
    },
    {
      "sent": "43 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 4,278 $ 1,428 $ 2,850 $ 2,850 $ 1.57 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 9 2 7 7 \u2014 Tobacco and health and certain other litigation items 58 14 44 44 0.02 JUUL changes in fair value 1,255 \u2014 1,255 1,255 0.70 ABI-related special items 53 11 42 42 0.02 Cronos-related special items 175 8 167 167 0.09 Income tax items \u2014 (9) 9 9 \u2014 2022 Adjusted for Special Items $ 5,768 $ 1,439 $ 4,329 $ 4,329 $ 2.38 2021 Reported $ 4,846 $ 1,275 $ 3,571 $ 3,573 $ 1.93 NPM Adjustment Items (32) (8) (24) (24) (0.01) Asset impairment, exit, implementation, acquisition and disposition-related costs 56 13 43 43 0.02 Tobacco and health and certain other litigation items 43 10 33 33 0.02 JUUL changes in fair value 100 \u2014 100 100 0.05 ABI-related special items (89) (18) (71) (71) (0.04) Cronos-related special items 111 (5) 116 116 0.06 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 (3) 3 3 \u2014 2021 Adjusted for Special Items $ 5,684 $ 1,417 $ 4,267 $ 4,269 $ 2.30 44 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 1,605 $ 714 $ 891 $ 891 $ 0.49 Asset impairment, exit, implementation, acquisition and disposition-related costs 2 \u2014 2 2 \u2014 Tobacco and health and certain other litigation items 46 11 35 35 0.02 JUUL changes in fair value 1,155 \u2014 1,155 1,155 0.64 ABI-related special items 112 23 89 89 0.05 Cronos-related special items 114 8 106 106 0.06 Income tax items \u2014 (4) 4 4 \u2014 2022 Adjusted for Special Items $ 3,034 $ 752 $ 2,282 $ 2,282 $ 1.26 2021 Reported $ 2,909 759 $ 2,150 $ 2,149 $ 1.16 Asset impairment, exit, implementation, acquisition and disposition-related costs 8 2 6 6 \u2014 Tobacco and health and certain other litigation items 8 1 7 7 \u2014 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 39 10 29 29 0.02 Cronos-related special items 181 (5) 186 186 0.10 Income tax items \u2014 (9) 9 9 \u2014 2021 Adjusted for Special Items $ 3,045 $ 758 $ 2,287 $ 2,286 $ 1.23 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11 and NPM Adjustment Items in Note 8, respectively.",
      "score": 0.9958
    },
    {
      "sent": "38 Table of Contents Consolidated Results of Operations for the Three Months Ended June 30, 2022 The changes in net earnings attributable to Altria and diluted EPS attributable to Altria for the three months ended June 30, 2022, from the three months ended June 30, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended June 30, 2021 $ 2,149 $ 1.16 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 6 \u2014 2021 Tobacco and health and certain other litigation items 7 \u2014 2021 JUUL changes in fair value (100) (0.05) 2021 ABI-related special items 29 0.02 2021 Cronos-related special items 186 0.10 2021 Income tax items 9 \u2014 Subtotal 2021 special items 137 0.07 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (2) \u2014 2022 Tobacco and health and certain other litigation items (35) (0.02) 2022 JUUL changes in fair value (1,155) (0.64) 2022 ABI-related special items (89) (0.05) 2022 Cronos-related special items (106) (0.06) 2022 Income tax items (4) \u2014 Subtotal 2022 special items (1,391) (0.77) Fewer shares outstanding \u2014 0.03 Change in tax rate 3 \u2014 Operations (7) \u2014 For the three months ended June 30, 2022 $ 891 $ 0.49 2022 Reported Net Earnings $ 891 $ 0.49 2021 Reported Net Earnings $ 2,149 $ 1.16 % Change (58.5) % (57.8) % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,282 $ 1.26 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,286 $ 1.23 % Change (0.2) % 2.4 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.",
      "score": 0.9893
    }
  ],
  "top_negative": [
    {
      "sent": "(4) Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "(4) Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.",
      "score": -0.8898
    }
  ],
  "forward_snippets": [
    "This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity.",
    "11 Table of Contents For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12.",
    "New Accounting Guidance Not Yet Adopted .",
    "This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity.",
    "11 Table of Contents For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12."
  ],
  "curated_text": "Symbol: MO. Year: 2022. Period: Q2. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: 43 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 4,278 $ 1,428 $ 2,850 $ 2,850 $ 1.57 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 9 2 7 7 \u2014 Tobacco and health and certain other litigation items 58 14 44 44 0.02 JUUL changes in fair value 1,255 \u2014 1,255 1,255 0.70 ABI-related special items 53 11 42 42 0.02 Cronos-related special items 175 8 167 167 0.09 Income tax items \u2014 (9) 9 9 \u2014 2022 Adjusted for Special Items $ 5,768 $ 1,439 $ 4,329 $ 4,329 $ 2.38 2021 Reported $ 4,846 $ 1,275 $ 3,571 $ 3,573 $ 1.93 NPM Adjustment Items (32) (8) (24) (24) (0.01) Asset impairment, exit, implementation, acquisition and disposition-related costs 56 13 43 43 0.02 Tobacco and health and certain other litigation items 43 10 33 33 0.02 JUUL changes in fair value 100 \u2014 100 100 0.05 ABI-related special items (89) (18) (71) (71) (0.04) Cronos-related special items 111 (5) 116 116 0.06 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 (3) 3 3 \u2014 2021 Adjusted for Special Items $ 5,684 $ 1,417 $ 4,267 $ 4,269 $ 2.30 44 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 1,605 $ 714 $ 891 $ 891 $ 0.49 Asset impairment, exit, implementation, acquisition and disposition-related costs 2 \u2014 2 2 \u2014 Tobacco and health and certain other litigation items 46 11 35 35 0.02 JUUL changes in fair value 1,155 \u2014 1,155 1,155 0.64 ABI-related special items 112 23 89 89 0.05 Cronos-related special items 114 8 106 106 0.06 Income tax items \u2014 (4) 4 4 \u2014 2022 Adjusted for Special Items $ 3,034 $ 752 $ 2,282 $ 2,282 $ 1.26 2021 Reported $ 2,909 759 $ 2,150 $ 2,149 $ 1.16 Asset impairment, exit, implementation, acquisition and disposition-related costs 8 2 6 6 \u2014 Tobacco and health and certain other litigation items 8 1 7 7 \u2014 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 39 10 29 29 0.02 Cronos-related special items 181 (5) 186 186 0.10 Income tax items \u2014 (9) 9 9 \u2014 2021 Adjusted for Special Items $ 3,045 $ 758 $ 2,287 $ 2,286 $ 1.23 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11 and NPM Adjustment Items in Note 8, respectively. 43 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 4,278 $ 1,428 $ 2,850 $ 2,850 $ 1.57 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 9 2 7 7 \u2014 Tobacco and health and certain other litigation items 58 14 44 44 0.02 JUUL changes in fair value 1,255 \u2014 1,255 1,255 0.70 ABI-related special items 53 11 42 42 0.02 Cronos-related special items 175 8 167 167 0.09 Income tax items \u2014 (9) 9 9 \u2014 2022 Adjusted for Special Items $ 5,768 $ 1,439 $ 4,329 $ 4,329 $ 2.38 2021 Reported $ 4,846 $ 1,275 $ 3,571 $ 3,573 $ 1.93 NPM Adjustment Items (32) (8) (24) (24) (0.01) Asset impairment, exit, implementation, acquisition and disposition-related costs 56 13 43 43 0.02 Tobacco and health and certain other litigation items 43 10 33 33 0.02 JUUL changes in fair value 100 \u2014 100 100 0.05 ABI-related special items (89) (18) (71) (71) (0.04) Cronos-related special items 111 (5) 116 116 0.06 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 (3) 3 3 \u2014 2021 Adjusted for Special Items $ 5,684 $ 1,417 $ 4,267 $ 4,269 $ 2.30 44 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Net Earnings Attributable to Altria Diluted EPS 2022 Reported $ 1,605 $ 714 $ 891 $ 891 $ 0.49 Asset impairment, exit, implementation, acquisition and disposition-related costs 2 \u2014 2 2 \u2014 Tobacco and health and certain other litigation items 46 11 35 35 0.02 JUUL changes in fair value 1,155 \u2014 1,155 1,155 0.64 ABI-related special items 112 23 89 89 0.05 Cronos-related special items 114 8 106 106 0.06 Income tax items \u2014 (4) 4 4 \u2014 2022 Adjusted for Special Items $ 3,034 $ 752 $ 2,282 $ 2,282 $ 1.26 2021 Reported $ 2,909 759 $ 2,150 $ 2,149 $ 1.16 Asset impairment, exit, implementation, acquisition and disposition-related costs 8 2 6 6 \u2014 Tobacco and health and certain other litigation items 8 1 7 7 \u2014 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 39 10 29 29 0.02 Cronos-related special items 181 (5) 186 186 0.10 Income tax items \u2014 (9) 9 9 \u2014 2021 Adjusted for Special Items $ 3,045 $ 758 $ 2,287 $ 2,286 $ 1.23 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11 and NPM Adjustment Items in Note 8, respectively. 38 Table of Contents Consolidated Results of Operations for the Three Months Ended June 30, 2022 The changes in net earnings attributable to Altria and diluted EPS attributable to Altria for the three months ended June 30, 2022, from the three months ended June 30, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the three months ended June 30, 2021 $ 2,149 $ 1.16 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 6 \u2014 2021 Tobacco and health and certain other litigation items 7 \u2014 2021 JUUL changes in fair value (100) (0.05) 2021 ABI-related special items 29 0.02 2021 Cronos-related special items 186 0.10 2021 Income tax items 9 \u2014 Subtotal 2021 special items 137 0.07 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (2) \u2014 2022 Tobacco and health and certain other litigation items (35) (0.02) 2022 JUUL changes in fair value (1,155) (0.64) 2022 ABI-related special items (89) (0.05) 2022 Cronos-related special items (106) (0.06) 2022 Income tax items (4) \u2014 Subtotal 2022 special items (1,391) (0.77) Fewer shares outstanding \u2014 0.03 Change in tax rate 3 \u2014 Operations (7) \u2014 For the three months ended June 30, 2022 $ 891 $ 0.49 2022 Reported Net Earnings $ 891 $ 0.49 2021 Reported Net Earnings $ 2,149 $ 1.16 % Change (58.5) % (57.8) % 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,282 $ 1.26 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,286 $ 1.23 % Change (0.2) % 2.4 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below. Top negative sentences: (4) Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. (4) Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. Forward-looking snippets: This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity. 11 Table of Contents For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. New Accounting Guidance Not Yet Adopted . This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity. 11 Table of Contents For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12."
}